Atavistik raises $120M for bleeding disorder, blood cancer drugs
Article Title: Atavistik Raises $120M for Bleeding Disorder, Blood Cancer Drugs Publication Date: December 18, 2025 Atavistik Bio, a company based in Cambridge, Massachusetts, has reportedly raised $120 million in Series B funding for its pipeline of small molecules for…